EHC Relative Valuation
EHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, EHC is overvalued; if below, it's undervalued.
Historical Valuation
Encompass Health Corp (EHC) is now in the Fair zone, suggesting that its current forward PE ratio of 21.45 is considered Fairly compared with the five-year average of 19.20. The fair price of Encompass Health Corp (EHC) is between 97.57 to 114.05 according to relative valuation methord.
Relative Value
Fair Zone
97.57-114.05
Current Price：110.01
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
5.14
P/B
Median3y
4.57
Median5y
4.42
3.47
FCF Yield
Median3y
2.80
Median5y
3.39
Competitors Valuation Multiple
The average P/S ratio for EHC's competitors is 1.83, providing a benchmark for relative valuation. Encompass Health Corp Corp (EHC) exhibits a P/S ratio of 1.85, which is 0.89% above the industry average. Given its robust revenue growth of 10.59%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Encompass Health Corp (EHC) currently overvalued or undervalued?
What is Encompass Health Corp (EHC) fair value?
How does EHC's valuation metrics compare to the industry average?
What is the current P/B ratio for Encompass Health Corp (EHC) as of Jul 20 2025?
What is the current FCF Yield for Encompass Health Corp (EHC) as of Jul 20 2025?
What is the current Forward P/E ratio for Encompass Health Corp (EHC) as of Jul 20 2025?